Our Partners
Building Governed AI Factories for Pharma
Pharma organisations in general are experimenting with AI across the business to drive innovation. Boston have delivered NVIDIA based solutions to support HCP’s need to leverage AI to turbocharge their research and extract information from their data. Boston is here to outline how marketing departments can take advantage of these technologies to optimise its messaging to HCP’s using business ready AI environments powered by NVIDIA AI Enterprise.
The real challenge isn’t AI itself. It’s deploying it reliably across your organisation.
Many teams face the same barriers. Balancing data security, access, and trust. Adhering to evolving regulatory requirements (EU AI Act, FDA guidance). How to measure ROI. Movement from isolated application-based trials to complex workflows that work at scale.
Boston Labs, our dedicated innovation and testing environment, allows exploration of NVIDIA-powered solutions, allows validation against regulatory requirements, and allows delivery into production with confidence.
What you’ll see on our stand:
- AI Agents for Pharma: Specialised agents that help teams find information faster, reduce manual effort and improve consistency in content creation, knowledge discovery and workflow automation. We’ll discuss how to design agents curated with your data while maintaining security.
- Omnichannel HCP Engagement: How NVIDIA technology can be used to deliver a consistent message to HCP’s, sales reps, email campaigns, website, seminar content and other channels.
- NVIDIA SPARK: A mini AI Factory that is a practical way to start your journey while being able to leverage NVIDIA’s vast ecosystem of tools.
- Governance that enables, not constrains: We can discuss how both Boston and other organisations have met the need to maintain security while adhering to regulatory requirements.
- How to access data: Techniques that should be used to access and curate your data ready to be used by AI.
For organisations just starting their AI journey:
Our Boston Future State AI Assessment evaluates your current readiness, identifies your highest-value opportunities, and builds a roadmap that connects AI investment directly to measurable business outcomes.
Come talk to us about:
Sovereign AI architectures | AI factories and scaling | Token economics and cost | Agentic workflows | Governance and compliance | Moving from experimentation to production
Boston Limited helps pharma deploy AI that is secure, scalable, trusted, and ready for real-world use.
Closing the Knowledge-to-Action Gap: How Cerebria Brain Is Shaping the Future of Medical Learning, Marketing, and Field Readiness
Cerebria.ai is an innovative medical artificial intelligence company transforming how pharmaceutical and healthcare organisations unlock, use, and scale knowledge across the enterprise. Built on the insight that critical expertise is often trapped within vast volumes of underutilised medical content, Cerebria converts existing materials – including clinical data, training assets, and scientific resources – into dynamic, interactive intelligence.
At the core of its offering is Cerebria Brain, an AI‑native, medical‑grade large language model platform that enables users to “ask” their organisation’s content and receive instant, context‑rich answers in over 100 languages. This capability transforms passive information into active engagement, supporting faster learning, improved retention, and more effective omnichannel communication across global teams.
Designed to meet the regulatory and scientific demands of the life sciences sector, Cerebria integrates seamlessly into existing systems, enabling scalable, personalised learning and knowledge delivery. Its advanced machine learning capabilities also support predictive insights, helping organisations enhance decision‑making, improve field readiness, and drive better patient and commercial outcomes.
Cerebria.ai’s mission is to accelerate knowledge transfer and empower organisations with intelligent, adaptive tools that elevate performance in an increasingly complex, data‑driven healthcare landscape.
Crescendo Collective: Applied AI for Pharma and Healthcare
The way people find answers has changed. They no longer browse and click their way to what they need. They ask, and they expect a response. For regulated brands, that shift rewrites how content reaches the people who depend on it.
We are an applied AI agency built for pharma and healthcare. Today we run digital operations for two of the world’s largest pharmaceutical companies, live and at global scale. Working in regulated industries is what we do. Compliance is built into everything we deploy, from the first line of content.
We take a brand’s own medically validated content and connect it straight through to the AI experiences customers and internal teams now expect. One trusted source, one direct path. Instead of a website people have to search, they get an experience that answers them directly. That same validated content is also what AI answer engines cite, so brands stay visible as search changes.
And because nothing reaches market in pharma without clearing MLR, we built accelerators for it. They strip the manual effort out of submission, so content moves into review and out to market faster. They also track content expiry automatically, so nothing quietly lapses out of compliance.
Speed, compliance, and AI that works inside your regulatory reality. That combination is rare. We think it is the future of how healthcare brands communicate.
Come find us. Bring your hardest content problem. We will show you what’s possible.
Digital Peloton unites AI, data, and pharma media expertise to power the next generation of marketing. Our DP Factori tools deliver predictive planning, omnichannel activation, and performance insights—with full control and compliance at global scale.
Your global Intelligent Commercialization™ partner.
We provide tailored, innovative solutions to help health and life sciences companies by connecting data, technology, and AI with expert insight to drive faster, smarter decision-making at every stage of the commercialization journey.
Leveraging our connected capabilities, our experts guide you through each pivotal moment in your asset’s lifecycle – simplifying the complex, unlocking value, and enhancing treatment outcomes and patient access.
Field-force conversations still run on a lag. Tracking studies take weeks to return, often landing well after the launch window has closed.
KAI closes that gap. Our patent-pending AI analyzes acoustic, linguistic, and visual signals in consent based HCP conversations, producing NetKonnector®, a conversation-level score of connection quality available in near real time.
Commercial and medical teams use it to track HCP sentiment and objections as they surface, coaching reps on empathy and active listening to see which messages are resonating.
KAI operates globally in 35+ markets and in 99+ languages.
5 of the world’s Top 10 pharmaceutical companies rely on it for commercial strategy and field coaching.
McKinsey research links stronger field-force communication to a 2 to 15% revenue uplift, and NetKonnector® gives teams the evidence they need to close that gap.
This is Behavioural Intelligence for Life Sciences: an objective layer between the conversations pharma teams have and the results they are driving.
KAI: Behaviour Change, Accelerated.
The Behavioural Intelligence Platform for Life Sciences
Find out more at http://www.kaiconversations.com
LEAP is a creative studio with global reach, crafting strategic, human-centered solutions. Our mastery lies in shaping the way people engage with content through the fusion of creativity, technology and design, pushing the boundaries of what’s possible.
For two decades, we’ve partnered with global pharmaceutical partners to transform complex scientific and medical information into engaging digital experiences. From HCP engagement, disease awareness and training to congress activations, internal communications and medical education, our projects bring greater impact, clarity and engagement to medical scientific communication.
Combining creativity with emerging technologies, we design and deliver interactive experiences, engaging activations and immersive simulations tailored to each strategic communication. Our multidisciplinary team creates solutions that make complex ideas and messages easier to understand, encourage meaningful engagement and bring data to life. Ultimately, everything we create is designed to transform complexity into clarity through experiences that inform, engage and create awareness.
Medisights is a frontier technology startup purpose-built for compliant life sciences insights at scale. Our AI-moderators aim to restore the qualitative depth in HCP interactions, which is then captured to build Digital Doctor Twins – pharma commercial teams can use these to actively “talk” to the data, test messaging and identify unmet needs. As a result, Medisights is actively reimagining a world beyond static insights stuck in PDFs.
Pantheon is the governed platform for the sites that matter. It helps organisations create, run and evolve web experiences across WordPress, Drupal, Next.js and other framework paths without forcing every team into a one-size-fits-all approach. As AI accelerates digital creation, Pantheon helps teams move faster while protecting brand standards, accessibility, security and accountability. P1 provides AI scaffolding for website creation and governance, connecting people and AI to shared context, approved components, permissions, collaboration, review and a reliable path to production.
At Publicis Health, we believe that keeping the world healthy is our most extraordinary social endeavour. Because one person’s wellbeing is the responsibility of the many.
Powered by agencies gifted in strategy, science and creativity from medical to wellness; we work together so healthcare can work its magic. We are transforming the way health is communicated, understood and experienced. We unlock our clients’ miraculous science to bring the power of good healthcare for everyone, everywhere, worldwide.
Find the hospitals treating the patients you need to reach.
Hospital data across Europe and Japan sits in different national systems, uses different coding schemes and appears in different languages. PurpleXtra brings it together, making it possible to see where patients with a particular condition are being treated, down to individual hospitals.
Our data covers 834 million hospital cases across 13,398 hospitals in 19 countries, representing a population of 604 million people, with up to ten years of history.
That detail matters because cases are rarely spread evenly. In most countries, fewer than 30% of hospitals account for around 70% of cases. Knowing which hospitals they are helps you focus clinical trials, field teams and launches where they can have the greatest impact.
AskPX, our AI assistant, turns plain-English questions into sourced charts, maps and reports you can share in seconds. You ask. You know.
19 countries | 834 million cases | 13,398 hospitals | Up to 10 years of history
Shaman is the leading no-code, do-it-yourself content authoring platform for Veeva Commercial Cloud, purpose-built for life sciences. Trusted by more than 3,000 marketing and medical content professionals across organisations including AstraZeneca, GSK, Novartis, Takeda, and Chiesi, Shaman enables teams to create, localise, reuse, and activate compliant multichannel content—from interactive CLM presentations and approved emails to landing pages and modular content—without design or coding skills.
Headquartered in Haarlem, the Netherlands, with employees in more than ten countries, Shaman is a certified Veeva Silver Product Partner and a recognised Veeva Content and AI Partner. The platform integrates natively with Veeva Vault PromoMats, keeping it as the single source of truth and ensuring compliance by design across every channel and market.
AI sits at the heart of Shaman’s approach to content excellence—embedded directly into authoring workflows to support teams rather than replace human judgment. Capabilities include MLR pre-checks, AI-assisted content comparison, intelligent reference checks, and AI-supported translation for global-to-local adaptation. Shaman’s next-generation solution, Aurora, brings together a team of specialised AI agents that co-create compliant, personalised emails through chat—turning campaign briefs into on-brand, MLR-ready drafts in minutes, with fewer review iterations and greater confidence from first submission.
The result is measurable impact at scale: customers report up to 80% reductions in time-to-market, significantly lower agency dependency, and stronger local adoption—bridging the gap between global strategy and local execution while keeping every asset compliant. More than a platform, Shaman is a strategic partner helping life sciences organisations transform how content is produced, governed, and brought to market.